Columbia University

Technology Ventures

Columbia-NYU-Takeda Alliance Request for Proposals

Deadline: 
Tuesday, February 23, 2021 - 12:00am

Columbia University, New York University, and Takeda Pharmaceuticals have formed a collaborative research alliance to initiate and advance gastroenterology (GI) research programs with high potential to impact the development of new therapeutics for patients with GI disorders. This cycle of the Alliance has a particular thematic focus on GI Inflammation and neuroinflammation; motility and modulating enteric nervous system biology; and liver.

We are issuing this Request for Proposals to advance sponsored research for 2021, the second year in the Alliance. The award decisions will be made by a Joint Research Committee comprised of research leaders from Columbia, NYU, and Takeda.

This application is open to all Columbia and NYU faculty. Early-career faculty are encouraged to apply.

The application process and funding framework is as follows:

  • Letter of Intent (LOI): A non-confidential level LOI submitted by February 22nd, 2021 Submissions will be collected here: https://takedaalliance.formstack.com/forms/columbia2021 (all information will be encrypted and held confidential). Selected applicants will be invited to submit Full Proposals. Please speak with your Technology Licensing Officer prior to submission.
  • Funding: $75,000 in direct costs for a ~1 year Pilot Project. Final budgets will be determined at the Full Proposal phase based on project needs. 

Please see the attached flyer and visit the Alliance Website for more information or contact:
Academic Alliance Manager: Mitchell Fullerton, [email protected]